Alpha Teknova (NASDAQ:TKNO) Rating Reiterated by Stephens

Alpha Teknova (NASDAQ:TKNO)‘s stock had its “overweight” rating restated by research analysts at Stephens in a research note issued to investors on Wednesday, Benzinga reports. They currently have a $5.00 price objective on the stock. Stephens’ price target indicates a potential upside of 303.23% from the stock’s previous close.

Separately, BTIG Research lowered Alpha Teknova from a “buy” rating to a “neutral” rating in a research note on Tuesday, March 12th.

Alpha Teknova Stock Performance

Shares of TKNO stock opened at $1.24 on Wednesday. The company has a debt-to-equity ratio of 0.16, a quick ratio of 3.92 and a current ratio of 5.52. The firm has a market capitalization of $50.62 million, a price-to-earnings ratio of -1.18 and a beta of 0.33. Alpha Teknova has a one year low of $1.16 and a one year high of $4.27. The company has a 50 day moving average price of $1.63 and a 200 day moving average price of $2.46.

Alpha Teknova (NASDAQ:TKNO) last released its quarterly earnings data on Monday, May 13th. The company reported ($0.20) EPS for the quarter, topping analysts’ consensus estimates of ($0.24) by $0.04. Alpha Teknova had a negative return on equity of 38.24% and a negative net margin of 97.85%. The business had revenue of $9.29 million during the quarter, compared to the consensus estimate of $7.80 million. During the same period in the prior year, the firm posted ($0.31) EPS. Sell-side analysts anticipate that Alpha Teknova will post -0.65 EPS for the current year.

Hedge Funds Weigh In On Alpha Teknova

Several hedge funds and other institutional investors have recently made changes to their positions in the business. FourWorld Capital Management LLC purchased a new position in Alpha Teknova in the first quarter valued at about $135,000. Fielder Capital Group LLC acquired a new stake in shares of Alpha Teknova in the fourth quarter valued at about $156,000. State Board of Administration of Florida Retirement System purchased a new stake in shares of Alpha Teknova during the 1st quarter valued at about $35,000. Redmile Group LLC lifted its position in Alpha Teknova by 6.5% during the 1st quarter. Redmile Group LLC now owns 171,453 shares of the company’s stock worth $434,000 after acquiring an additional 10,448 shares in the last quarter. Finally, Conestoga Capital Advisors LLC boosted its holdings in Alpha Teknova by 4.1% in the 4th quarter. Conestoga Capital Advisors LLC now owns 247,529 shares of the company’s stock worth $923,000 after acquiring an additional 9,800 shares during the period. Institutional investors and hedge funds own 13.81% of the company’s stock.

Alpha Teknova Company Profile

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.